Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients

<div>(a) Gene ontology (GO) analysis shows enriched GO term. (b) Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis shows enriched signaling pathways. (c) Protein-protein interaction analysis. (d) Hub genes were found and ranked by Cytoscape and Cytohubba.</div>

Journal of Oncology

fig6

Figure 6

Figure 6: Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients 

Figure 6 | Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients 